TNFAIP3 mutation is an independent poor overall survival factor for patients with T-cell acute lymphoblastic leukemia.

Cunte ChenLingling ZhouLihua ZhuGengxin LuoLiang WangChengwu ZengHongsheng ZhouYangqiu Li

Published in: Cancer medicine (2022)

TNFAIP3 mutation mainly occurs in adult T-ALL patients, and it was associated with adverse clinical outcomes for T-ALL patients; thus, it might be a biomarker for prognostic stratification.

Keyphrases

end stage renal disease
acute lymphoblastic leukemia
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
emergency department
patient reported outcomes
drug induced